<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Primary <z:hpo ids='HP_0002665'>lymphoma</z:hpo> of the liver (<z:chebi fb="1" ids="53412">PLL</z:chebi>) is rare </plain></SENT>
<SENT sid="1" pm="."><plain>In some cases, the hepatic <z:hpo ids='HP_0002665'>lymphoma</z:hpo> has been diagnosed in patients who were infected by the <z:hpo ids='HP_0012115'>hepatitis</z:hpo> C virus (HCV) </plain></SENT>
<SENT sid="2" pm="."><plain>It has been suggested that HCV plays a role in the pathogenesis of <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>The aim of our multicentric retrospective study was to assess the characteristics of <z:chebi fb="1" ids="53412">PLL</z:chebi> and to determine the prevalence of HCV <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> in <z:chebi fb="1" ids="53412">PLL</z:chebi> </plain></SENT>
<SENT sid="4" pm="."><plain>Thirty-one immunocompetent patients (anti-human <z:hpo ids='HP_0002721'>immunodeficiency</z:hpo> virus, anti-human T-cell <z:hpo ids='HP_0001909'>leukemia</z:hpo>/<z:hpo ids='HP_0002665'>lymphoma</z:hpo> virus negative, no history of allograft) with <z:chebi fb="1" ids="53412">PLL</z:chebi> fulfilled the entire selection criteria </plain></SENT>
<SENT sid="5" pm="."><plain>The liver biopsy specimens were reassessed by the same pathologist </plain></SENT>
<SENT sid="6" pm="."><plain>The non-Hodgkin's <z:hpo ids='HP_0002665'>lymphomas</z:hpo> were classified according to the World Health Organization classification </plain></SENT>
<SENT sid="7" pm="."><plain>Blood samples were tested in 28 patients for antibodies to HCV, and HCV <z:chebi fb="40" ids="33697">RNA</z:chebi> was detected by reverse transcription polymerase chain reaction </plain></SENT>
<SENT sid="8" pm="."><plain>In the majority of cases, the clinical, biologic, and radiologic data were nonspecific </plain></SENT>
<SENT sid="9" pm="."><plain>Twenty-seven of 31 patients presented a B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> corresponding to the <z:e sem="disease" ids="C1516391" disease_type="Neoplastic Process" abbrv="">centroblastic</z:e> morphologic variant of a diffuse, large B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (22 cases), a Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (1 case), an extranodal marginal zone B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> of mucosa-associated lymphoid tissue type (3 cases), and unclassified, small B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (1 case) </plain></SENT>
<SENT sid="10" pm="."><plain>The 4 other cases were T-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
<SENT sid="11" pm="."><plain>The prevalence of HCV <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> was 21% (6 of 28 cases) </plain></SENT>
<SENT sid="12" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> of these patients were positive for HCV <z:chebi fb="40" ids="33697">RNA</z:chebi> by polymerase chain reaction in blood </plain></SENT>
<SENT sid="13" pm="."><plain>Most of the HCV-infected patients presented a high-grade, B-cell type <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="14" pm="."><plain>In conclusion, our study confirms the rarity of <z:chebi fb="1" ids="53412">PLL</z:chebi> and demonstrates an increased prevalence of HCV <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> </plain></SENT>
</text></document>